EPO and COVID-19: A drop in hemoglobin or hematocrit levels may indicate the need for erythropoietin treatment, oxygen supplementation, and blood transfusions and should warn physicians of the potential for severe hypoxia, systemic inflammation, or organ malfunction common in severe COVID‐19 patients [21].